Literature DB >> 3530862

Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.

P De Feo, G Perriello, M M Ventura, F Calcinaro, G Basta, C Lolli, C Cruciani, A Dell'Olio, F Santeusanio, P Brunetti.   

Abstract

In order to assess whether the metabolic clearance of insulin changes overnight, 11 patients with Type 1 (insulin-dependent) diabetes and low insulin antibody titre, and 6 nondiabetic subjects were studied. In these studies insulin was always infused by a Harvard pump. Initially, the nocturnal insulin requirements were assessed in the diabetic patients by an overnight feedback insulin infusion to maintain euglycaemia. The insulin requirements decreased continuously after midnight to a nadir of 0.115 +/- 0.014 mU X kg-1 X min-1 at 04.30 hours, but after 05.00 hours the insulin requirements increased nearly 40 percent to a maximum of 0.16 +/- 0.012 mU X kg-1 X min-1 at 07.00 hours. To assess whether plasma insulin clearance changes overnight, the diabetic patients were studied on two different occasions, from 22.00-02.30 hours and from 04.00-08.30 hours. During each of these two studies insulin was infused in sequential steps of 90 min each at the rate of 0.13, 0.40 and 0.20 mU X kg-1 X min-1. Despite changes in plasma free insulin concentration, the metabolic clearance of insulin in the interval 22.00-02.30 hours (12.6 +/- 0.17 ml X kg-1 X min-1) was no different from that of the interval 04.00-08.30 hours (12.5 +/- 0.19 ml X kg-1 X min-1). The nondiabetic subjects were studied on two different occasions to assess whether the metabolic clearance of insulin changes overnight. Somatostatin (0.25 mg/h) and insulin (0.3 mU X kg-1 X min-1) were infused from 22.00-02.30 hours on one occasion, and from 04.00-08.30 hours on the other.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530862     DOI: 10.1007/bf00453496

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

Authors:  E A McGuire; J H Helderman; J D Tobin; R Andres; M Berman
Journal:  J Appl Physiol       Date:  1976-10       Impact factor: 3.531

2.  Fasting early morning rise in peripheral insulin: evidence of the dawn phenomenon in nondiabetes.

Authors:  M I Schmidt; Q X Lin; J T Gwynne; S Jacobs
Journal:  Diabetes Care       Date:  1984 Jan-Feb       Impact factor: 19.112

3.  Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitus.

Authors:  P J Campbell; J E Gerich
Journal:  Diabetes       Date:  1986-07       Impact factor: 9.461

4.  Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans.

Authors:  P R Bratusch-Marrain; W K Waldhäusl; S Gasić; A Hofer
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

5.  Modeling of plasma disappearance of unlabeled insulin in man.

Authors:  K G Tranberg; H Dencker
Journal:  Am J Physiol       Date:  1978-12

6.  Relative roles of insulin clearance and insulin sensitivity in the prebreakfast increase in insulin requirements in insulin-dependent diabetic patients.

Authors:  D A Skor; N H White; L Thomas; J V Santiago
Journal:  Diabetes       Date:  1984-01       Impact factor: 9.461

7.  Dose-response characteristics for effects of insulin on production and utilization of glucose in man.

Authors:  R A Rizza; L J Mandarino; J E Gerich
Journal:  Am J Physiol       Date:  1981-06

8.  Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.

Authors:  P J Campbell; G B Bolli; P E Cryer; J E Gerich
Journal:  N Engl J Med       Date:  1985-06-06       Impact factor: 91.245

9.  Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.

Authors:  J Wahren
Journal:  Lancet       Date:  1976-12-04       Impact factor: 79.321

10.  Pump-induced insulin aggregation. A problem with the Biostator.

Authors:  J R Brennan; S S Gebhart; W G Blackard
Journal:  Diabetes       Date:  1985-04       Impact factor: 9.461

View more
  17 in total

Review 1.  Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy.

Authors:  L Monnier; C Colette; S Dejager; D R Owens
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

2.  Modeling the acute effects of exercise on insulin kinetics in type 1 diabetes.

Authors:  Spencer Frank; Abdulrahman Jbaily; Ling Hinshaw; Rita Basu; Ananda Basu; Andrew J Szeri
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-11-03       Impact factor: 2.745

3.  Letter to the editor. A study that glucose control can be achieved in 31 type 1 patients who follow a controlled diet and use an insulin pump that is programmed.

Authors:  John Walsh; Ruth Roberts
Journal:  J Diabetes Sci Technol       Date:  2007-07

4.  Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Perriello; E Torlone; S Di Santo; C Fanelli; P De Feo; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

5.  The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

6.  Non-linearity of insulin kinetics.

Authors:  B Thorsteinsson; S Fugleberg; C Binder
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

7.  Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1990-01       Impact factor: 10.122

8.  Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.

Authors:  B Beaufrère; M Beylot; C Metz; A Ruitton; R François; J P Riou; R Mornex
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

9.  ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.

Authors:  E Torlone; A M Rambotti; G Perriello; G Botta; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

10.  Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia.

Authors:  S Pampanelli; C Fanelli; C Lalli; M Ciofetta; P D Sindaco; M Lepore; F Modarelli; A M Rambotti; L Epifano; A Di Vincenzo; L Bartocci; B Annibale; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.